H.R. 2999 · 115th Congress
Patients' Access to Treatments Act of 2017
- Stage
- In committee
- Sponsor
- David McKinley
- Introduced
- 2017-06-22
- Latest action
- 2017-06-23 · Referred to the Subcommittee on Health.
Summary
Patients' Access to Treatments Act of 2017
This bill amends the Public Health Service Act to establish cost sharing limits for health plans that cover prescription drugs and use a formulary or other tiered cost sharing structure. Such health plans may not impose higher cost sharing requirements, including copayment and coinsurance, for specialty drugs than for other prescription drugs in a nonpreferred brand name drug tier. If a health plan's formulary contains more than one nonpreferred brand name drug tier, the tier with the lowest cost sharing applies.